Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02186717 · ClinicalTrials.gov registry record · NA

Does Chewing Gum Hasten Return of Bowel Function Post-Operatively in Patients Undergoing Spinal Surgery

A NA study, sponsored by Hospital for Special Surgery, New York.

Completed
Registry status
NA
Development phase
144
Enrollment target

NCT02186717 is a NA study that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 144 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02186717, a NA study, has completed, sponsored by Hospital for Special Surgery, New York.

COMPLETED
Registry status
NA
Development phase
144 participants
Enrollment target

Study Summary

The specific aim of this prospective, randomized controlled trial is to compare the effect of chewing gum on the return of bowel function in a group of patients undergoing spinal surgery with a group of matched controls that do not receive any chewing gum. A 24-hour reduction in time to passage of first flatus will be considered an important clinical difference. The research questions are: 1. Does providing chewing gum post-operatively hasten the return of bowel function? 2. Does providing chewing gum post-operatively reduced overall length of stay? 3. Does providing chewing gum post-operatively have any associated complications? 4. Does providing chewing gum post-operatively result in higher objective outcomes scores? The secondary aims are: 1. To compare hospital length of stay between the groups with a mean of ½ day considered clinically important. 2. To compare time until tolerating regular diet as defined as two consecutive meals with no complications with 24 hours considered statistically significant. 3. To compare incidence and nature of complications between the two groups. 4. To compare the time until completion of rehab milestones with 1 day being considered clinically important. 5. To compare the requirement for nutrition evaluations 6. To compare SF-12 scores as a marker of patient satisfaction with a difference of 10 points or more measured between the two groups upon discharge from hospital and at six-weeks after surgery.

Interventions

  • DIETARY_SUPPLEMENT Chewing gum

Trial Details

FieldValue
Enrollment Target 144 participants
Start Date 2014-06
Est. Completion 2016-06
Phase NA

What the Registry Record Tells You About NCT02186717

The ClinicalTrials.gov registry entry for NCT02186717 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Chewing gum is the first listed.

NCT02186717 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02186717 about?

NCT02186717 is a clinical study titled "Does Chewing Gum Hasten Return of Bowel Function Post-Operatively in Patients Undergoing Spinal Surgery". The specific aim of this prospective, randomized controlled trial is to compare the effect of chewing gum on the return of bowel function in a group of patients undergoing spinal surgery with a group of matched controls that do not receive any chewing gum. A 24-hour reduction in time to passage of f...

What is the current status of trial NCT02186717?

This trial is currently completed. It is a NA study. The enrollment target is 144 participants. The study started on 2014-06. Estimated completion is 2016-06.

What interventions are being tested in trial NCT02186717?

The interventions under investigation include: Chewing gum (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02186717?

This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.